Sinopharm Group (SHTDF) News Today $2.49 -0.06 (-2.35%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Headlines Stock AnalysisChartFinancialsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Sinopharm Group: The Focus Is On Working Capital And ProfitabilityNovember 22, 2024 | seekingalpha.comSinopharm Group’s Asset Growth Boosts Investor ConfidenceOctober 28, 2024 | markets.businessinsider.comSinopharm Group Co. Reports Mixed Financial ResultsOctober 28, 2024 | markets.businessinsider.comSinopharm Group Shares Fall as Higher Costs Cut Into Quarterly ProfitApril 29, 2024 | marketwatch.comSinopharm Group Co Ltd ADR X2S1April 6, 2024 | morningstar.comSinopharm Group Co Ltd 01099February 21, 2024 | morningstar.comSinopharm Group Co Ltd X2SJanuary 30, 2024 | morningstar.comSinopharm Group Co Ltd SHTDFNovember 8, 2023 | morningstar.comSinopharm Group (HKEX:1099) Price Target Increased by 8.31% to 29.48May 12, 2023 | msn.comPfizer signs strategic cooperation pact with China's SinopharmApril 13, 2023 | finance.yahoo.comWHO chief expects COVID emergency to end this yearApril 6, 2023 | msn.comChina approves its first mRNA Covid-19 vaccineMarch 24, 2023 | msn.comChina approves first home-grown mRNA Covid vaccineMarch 22, 2023 | news.yahoo.comSinopharm GroupFebruary 23, 2023 | forbes.comSinopharm unit gets OK for clinical trials of mRNA COVID vaccineJanuary 20, 2023 | news.yahoo.comPharma major Sinopharm gets approval for clinical trials of mRNA Covid-19 vaccineJanuary 20, 2023 | msn.comSinopharm's second Chinese herb shot is potentDecember 8, 2022 | reuters.comVaxxinity says COVID vaccine outperformed Astra and Sinopharm shots as boosterDecember 2, 2022 | seekingalpha.comMerck in pact with Sinopharm to launch oral COVID-19 therapy in ChinaSeptember 28, 2022 | seekingalpha.comSinopharm to boost local COVID vaccine production in AfricaSeptember 15, 2022 | msn.comChina’s Sinovac to test Omicron-targeting vaccines in ChileSeptember 7, 2022 | msn.comDaesang to set up joint venture with China Sinopharm InternationalJuly 27, 2022 | msn.comWeek In Review: Qiming Closes $3.2 Billion For China Healthcare And Technology InvestmentsJuly 17, 2022 | seekingalpha.comHong Kong could have 3 Omicron-targeting jabs by end of year, as health expert reveals Sinopharm hopes to make new vaccine available by DecemberJuly 4, 2022 | msn.comChina Donates 10 Mil Doses of Sinopharm COVID-19 Vaccines, SyringesJune 27, 2022 | msn.comSome Omicron Sub-Variants Escaping Antibodies From Sinopharm Shot -Chinese StudyJune 22, 2022 | usnews.comSome Omicron sub-variants escaping antibodies from Sinopharm shot - Chinese studyJune 21, 2022 | reuters.comUniversity of Hong Kong, Sinopharm launch city’s first trial for Omicron-targeting vaccine which could be ready in NovemberMay 31, 2022 | msn.comCanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?May 28, 2022 | seekingalpha.comSinovac Biotech's Omicron-specific vaccine cleared for clinical trial in Hong KongApril 18, 2022 | seekingalpha.comSinopharm, Sinovac vaccine candidates for Omicron variant gets clearance for clinical trialApril 16, 2022 | msn.comSinopharm Says Second-Generation Vaccine Approved for TrialApril 3, 2022 | bloomberg.comAntibody triggered by Sinopharm COVID booster wanes after six months - studyFebruary 22, 2022 | reuters.comAbu Dhabi makes fourth doses of Pfizer and Sinopharm Covid-19 vaccines availableFebruary 9, 2022 | msn.comAll required data received for Sinopharm vaccine to be registered - SahpraFebruary 8, 2022 | msn.comSahpra registers Sinopharm, Pfizer COVID-19 vaccines for use in SAFebruary 7, 2022 | msn.comSinopharm Group Co Ltd (SHTDF)January 14, 2022 | nasdaq.comDuterte receives Sinopharm COVID-19 boosterJanuary 7, 2022 | msn.comWHO: shots such as Sinopharm and Sinovac prevent 'severe hospitalisation' from OmicronJanuary 5, 2022 | msn.comSinopharm Covid-19 vaccine now available in MalaysiaOctober 15, 2021 | msn.comSinopharm vaccine now available at GPs, private hospitalsOctober 15, 2021 | msn.comWHO group backs third Covid-19 shot for elderly vaccinated with Sinovac or SinopharmOctober 12, 2021 | msn.comChromaDex Partners with Sinopharm Xingsha for Cross-Border Sales of Tru Niagen® into Mainland ChinaSeptember 29, 2021 | businesswire.comChina’s Sinopharm Group contemplates vaccine plant in SLSeptember 9, 2021 | msn.comDuopharma denies appointing Bintai Healthcare, other parties as distributor of Sinopharm's Covid-19 vaccineSeptember 8, 2021 | msn.comSinopharm Covid Vaccine Seen as Less Effective in Bahrain StudyAugust 29, 2021 | wsj.comCuba to deploy China's Sinopharm alongside homegrown vaccinesAugust 29, 2021 | msn.comCoronavirus: Sinopharm’s twin approach to variants aims for improved vaccine while testing booster shotAugust 25, 2021 | msn.comSinopharm executive suggests vaccinated people accept booster shots after China builds herd immunity - Global TimesAugust 24, 2021 | msn.comSinopharm vaccine gets EUA from FDAAugust 23, 2021 | msn.com Get Sinopharm Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SHTDF and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin SHTDF Media Mentions By Week SHTDF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SHTDF News Sentiment▼0.000.60▲Average Medical News Sentiment SHTDF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SHTDF Articles This Week▼00▲SHTDF Articles Average Week Get Sinopharm Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SHTDF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AALBF News Today AGRPY News Today EADSF News Today AIPUY News Today AKBTY News Today AABB News Today DFRYF News Today BMDPF News Today BRDCY News Today BEDU News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SHTDF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinopharm Group Co. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinopharm Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SHTDF Stock Alerts